169 related articles for article (PubMed ID: 38282047)
1. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.
Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3/miR-124-3p/MTDH axis.
Shi P; Liu Y; Yang H; Hu B
Cell Signal; 2022 Jul; 95():110338. PubMed ID: 35460835
[TBL] [Abstract][Full Text] [Related]
4. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
[TBL] [Abstract][Full Text] [Related]
5. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
7. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
[TBL] [Abstract][Full Text] [Related]
8. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
10. Exosome-delivered miR-410-3p reverses epithelial-mesenchymal transition, migration and invasion of trophoblasts in spontaneous abortion.
Chen ZY; Li Z; Zong Y; Xia B; Luo SP; Deng GP; Gao J
J Cell Mol Med; 2024 Feb; 28(3):e18097. PubMed ID: 38164738
[TBL] [Abstract][Full Text] [Related]
11. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
El Din GS; Youness RA; Assal RA; Gad MZ
Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
13. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
14. Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.
Li XJ; Ren ZJ; Tang JH; Yu Q
Cell Physiol Biochem; 2017; 44(5):1741-1748. PubMed ID: 29216623
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-22-3p derived from peritoneal macrophages enhances proliferation, migration, and invasion of ectopic endometrial stromal cells through regulation of the SIRT1/NF-κB signaling pathway.
Zhang L; Li HH; Yuan M; Li D; Wang GY
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):571-580. PubMed ID: 32016958
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
Shi Y; Liu C
BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
[TBL] [Abstract][Full Text] [Related]
19. Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis.
Yu Q; Zhang Y; Tian Y; Peng A; Cui X; Ding B; Yang L; Liu Y; Ju Y; Gao C
Appl Biochem Biotechnol; 2023 Dec; 195(12):7322-7337. PubMed ID: 36995659
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
